SNAP has posted its strongest weekly gain in months — up 21% to $5.79 — yet every analyst who updated their view after earnings refused to upgrade the stock.
The tension in the data is straightforward. Ten firms moved their price targets on August 4. Nine raised them. One cut. And every single one kept a neutral or equivalent rating. Mizuho lifted to $6, Wells Fargo to $6, and Evercore went furthest at $8 — but none crossed the line to Buy. The consensus holds at Hold, with a mean target of $7.26, implying roughly 25% upside from current levels. That gap is real. The reluctance to close it tells you something. Bears point to persistent ad tool competitiveness concerns, murky monetisation visibility, and ongoing uncertainty around the Perplexity deal. Bulls anchor on AR Spectacles and longer-dated product innovation — a thesis that requires patience the Street is not yet willing to reward with a positive rating. The analyst recommendation differential factor scores in the 96th percentile, meaning the gap between where analysts have Snap rated and where the stock has moved is near an extreme.
Positioning is loose — and getting looser. Short interest has continued its post-July-22 decline, easing a further 5.8% on the week to 5.82% of free float, around 85 million shares. That is down from over 110 million a fortnight ago. The exodus that began ahead of the July 30 print has not reversed. Borrow conditions reflect it: availability has expanded to over 1,550% — more than fifteen shares available to borrow for every one currently lent out, near the highest level of the past year. Cost to borrow, while up 55% on the week in percentage terms, remains negligible in absolute terms at 0.39%. There is no squeeze pressure, and no sign the remaining short base is under stress. Shorts who left before earnings did so cleanly; those who remain are sitting on ample room.
Options are slightly more cautious than usual, though far from alarmed. The put/call ratio ticked up to 0.25 on August 4 — about 1.3 standard deviations above its 20-day average of 0.24. That is a mild defensive lean, not the 3.6-sigma spike that preceded the August 5 print earlier this week. The options market has absorbed the earnings event and reset closer to neutral. The 52-week high PCR of 0.57 is a long way off; the current reading sits near the low end of the year's range, consistent with a stock that has just rallied hard rather than one facing fresh uncertainty.
Where the data gets genuinely interesting is in the earnings reaction itself. The most recent print on August 3 delivered a 23.5% next-day move. The July 30 event produced a modest -0.85% reaction. That dispersion — from flat to nearly a quarter of the stock's value in one session — reflects how binary the Snap story remains. With a second earnings event flagged for August 5, the reaction pattern is worth watching closely. Peer performance this week was mixed: GOOGL rose 13% on the week while PINS added 5%, suggesting some sector tailwinds. RDDT, however, fell over 10%, a reminder that the ad-dependent social media trade is not uniformly rewarded.
Insider activity over the past 90 days has been net positive in share terms at roughly 4.9 million shares — but the composition matters. The bulk of recent individual transactions are sells: co-founder Robert Murphy sold over 343,000 shares in late May for $2 million, the CFO sold across two days in May for nearly $1.35 million combined, and General Counsel Zachary Briers sold in both May and June. These are modest as a percentage of shares outstanding, but the directional flow from insiders is clearly outward. No purchases are visible in the recent history.
The number to watch now is whether the analyst consensus begins to shift — either target upgrades narrowing that 25% gap or, eventually, a rating change — as the distance between where the stock trades and where analysts are willing to bless it becomes harder to justify.
See the live data behind this article on ORTEX.
Open SNAP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
